The compound cis-(dichloro)tetrammineruthenium(III) chloride induces caspase-mediated apoptosis in K562 cells.

作者: Aliny Pereira de Lima , Flávia de Castro Pereira , Cesar Augusto Sam Tiago Vilanova-Costa , Francyelli Mariana dos Santos Mello , Alessandra de Santana Braga Barbosa Ribeiro

DOI: 10.1016/J.TIV.2010.06.015

关键词: Cyclosporin aMitochondrial permeability transition poreK562 cellsCytotoxic T cellBiochemistryTrypan blueBiologyChlorideApoptosisCytotoxicity

摘要: Abstract Ruthenium(III) complexes are increasingly attracting the interest of researchers due to their promising pharmacological properties. In present study, we investigated ability cis-(dichloro)tetrammineruthenium(III) chloride produce lethal effects in human chronic myelogenous leukemia K562 cells. The MTT tetrazolium reduction test and trypan blue exclusion assay revealed that IC50 for compound after 48 h incubation with cells was approximately 10.74 73.45 μM, respectively. Interestingly, it observed this exhibits mild cytotoxicity towards MRC-5 fibroblast (IC50 > 383 μM). Flow cytometric analysis capable change cell cycle distribution since percentage G1, S G2 phases decreased. addition, treatment induced apoptotic death cells, demonstrated by increased DNA content sub-G1-peak a significant increase caspase-3 activity. Assay using cyclosporin A, an inhibitor mitochondrial permeability transition pore (MPT) showed preincubation had not effect on activation. summary, displayed cytotoxic through arrest induction which suggests might have therapeutic potential against leukemia.

参考文章(42)
Philipp le Coutre, Elena Tassi, Marileila Varella-Garcia, Rossella Barni, Luca Mologni, Gonçalo Cabrita, Edoardo Marchesi, Rosanna Supino, Carlo Gambacorti-Passerini, Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification. Blood. ,vol. 95, pp. 1758- 1766 ,(2000) , 10.1182/BLOOD.V95.5.1758.005A41_1758_1766
A Bedi, JP Barber, GC Bedi, WS el-Deiry, D Sidransky, MS Vala, AJ Akhtar, J Hilton, RJ Jones, BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents Blood. ,vol. 86, pp. 1148- 1158 ,(1995) , 10.1182/BLOOD.V86.3.1148.1148
V Scarcia, G Sava, A Furlani, R Gagliardi, E Alessio, A Bergamo, G Mestroni, In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin. Journal of Pharmacology and Experimental Therapeutics. ,vol. 289, pp. 559- 564 ,(1999)
Gerald M. COHEN, Caspases: the executioners of apoptosis Biochemical Journal. ,vol. 326, pp. 1- 16 ,(1997) , 10.1042/BJ3260001
Bastiano Sanna, Marcella Debidda, Gianfranco Pintus, Bruna Tadolini, Anna M. Posadino, Federico Bennardini, Gianni Sava, Carlo Ventura, The anti-metastatic agent imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate induces endothelial cell apoptosis by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase signaling pathway Archives of Biochemistry and Biophysics. ,vol. 403, pp. 209- 218 ,(2002) , 10.1016/S0003-9861(02)00218-7
Elisângela de Paula Silveira-Lacerda, Cesar Augusto Sam Tiago Vilanova-Costa, Flávia de Castro Pereira, Amélia Hamaguchi, Luiz Alfredo Pavanin, Luiz Ricardo Goulart, Maria Inês Homsi-Brandenburgo, Andreimar Martins Soares, Wagner Batista dos Santos, Auro Nomizo, None, The Ruthenium Complex cis-(Dichloro)Tetraammineruthenium(III) Chloride Presents Immune Stimulatory Activity on Human Peripheral Blood Mononuclear Cells Biological Trace Element Research. ,vol. 133, pp. 270- 283 ,(2010) , 10.1007/S12011-009-8440-8
Scott H. Kaufmann, William C. Earnshaw, Induction of apoptosis by cancer chemotherapy. Experimental Cell Research. ,vol. 256, pp. 42- 49 ,(2000) , 10.1006/EXCR.2000.4838
Elisângela de Paula Silveira-Lacerda, Cesar Augusto Sam Tiago Vilanova-Costa, Amélia Hamaguchi, Luiz Alfredo Pavanin, Luiz Ricardo Goulart, Maria Inês Homsi-Brandenburgo, Wagner Batista Dos Santos, Andreimar Martins Soares, Auro Nomizo, None, The Ruthenium Complex cis -(Dichloro)tetraammineruthenium(III) Chloride Presents Selective Cytotoxicity Against Murine B Cell Lymphoma (A-20), Murine Ascitic Sarcoma 180 (S-180), Human Breast Adenocarcinoma (SK-BR-3), and Human T Cell Leukemia (Jurkat) Tumor Cell Lines Biological Trace Element Research. ,vol. 135, pp. 98- 111 ,(2010) , 10.1007/S12011-009-8498-3
C. Gaiddon, P. Jeannequin, P. Bischoff, M. Pfeffer, C. Sirlin, J. P. Loeffler, Ruthenium (II)-Derived Organometallic Compounds Induce Cytostatic and Cytotoxic Effects on Mammalian Cancer Cell Lines through p53-Dependent and p53-Independent Mechanisms Journal of Pharmacology and Experimental Therapeutics. ,vol. 315, pp. 1403- 1411 ,(2005) , 10.1124/JPET.105.089342